SEC Comment Letter 0000000000-26-005598 to CITIUS ONCOLOGY, INC. (CTOR)
CITIUS ONCOLOGY, INC.
Date: June 3, 2026 · CIK: 0001851484 · Accession: 0000000000-26-005598
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-296360
Letter
June 3, 2026 Leonard Mazur Chief Executive Officer Citius Oncology, Inc. 11 Commerce Drive, First Floor Cranford, New Jersey 07016 Re: Citius Oncology, Inc. Registration Statement on Form S-3 Filed May 29, 2026 File No. 333-296360 Dear Leonard Mazur: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Chris Edwards at 202-551-6761 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Christopher P. Agoranos, Esq.
Show Raw Text
June 3, 2026 Leonard Mazur Chief Executive Officer Citius Oncology, Inc. 11 Commerce Drive, First Floor Cranford, New Jersey 07016 Re: Citius Oncology, Inc. Registration Statement on Form S-3 Filed May 29, 2026 File No. 333-296360 Dear Leonard Mazur: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Chris Edwards at 202-551-6761 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Christopher P. Agoranos, Esq.